Arrowhead Pharmaceuticals Inc.
58.12 - 60.82
19.51 - 73.72
Echofin Members Consensus
Next Dividend Date
Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
CEO: Christopher Richard Anzalone
HQ: 177 East Colorado Boulevard Pasadena, 91105 CA